Most of our BPC-157 patients on Chicago's North Side share a similar profile: they are active, health-conscious adults between 30 and 65 who have done their research
Not for human consumption, therapeutic use, or medical application
Each review covers the source type, relevant compounds, available documentation, and accessibility for researchers
For example: FDA communications indicate AOD-9604 was removed from Category 2 in 2024 because nominations were withdrawn, while also noting FDA would consult the Pharmacy Compounding Advisory Committee (PCAC) about potential inclusion on the 503A bulks list
These findings add to the growing need for improved tolerability of weight loss solutions to help people not only lose weight but keep their weight off by acting in a fast-onset, short-duration manner with very high tolerability. -- Session: Poster Presentation -- Date/Time: Tuesday, November 4, 2025 | 7:30 p.m
Safety and Considerations While B12 injections are generally safe, its important to receive them from qualified professionals